Zogenix to Participate in Stifel 2014 Healthcare Conference
12 nov. 2014 16h30 HE
|
Zogenix
SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central...
Zogenix Reports Third Quarter 2014 Financial Results
06 nov. 2014 16h05 HE
|
Zogenix
Conference Call and Webcast Today, November 6, at 4:30 p.m. ET
Recent Business Highlights
Submitted a supplemental New Drug Application (sNDA) for a modified formulation with potential abuse...
Zogenix and Purdue Pharma Exchange Waivers of Regulatory Exclusivity for Extended-Release Hydrocodone Products
31 oct. 2014 08h30 HE
|
Zogenix
SAN DIEGO, Oct. 31, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system...
Zogenix Announces Conference Call and Webcast to Present Third Quarter 2014 Financial Results
30 oct. 2014 16h15 HE
|
Zogenix
SAN DIEGO, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system...
Zogenix Acquires U.K.-Based Brabant Pharma
27 oct. 2014 07h30 HE
|
Zogenix
Obtains global rights for treatment option in development for Dravet syndrome, a rare and catastrophic form of epilepsy that begins in infancy
Plans to initiate Phase 3 clinical studies of...
Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review
01 oct. 2014 08h30 HE
|
Zogenix
SAN DIEGO, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system...
New Data Shows Zohydro(R) ER Reduced Pain and Improved Function in People With Chronic Pain
18 sept. 2014 08h30 HE
|
Zogenix
PHOENIX, Sept. 18, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system...
Education, Patient-Focused Approach to Treating Chronic Pain Are Keys to Preventing Opioid Abuse, Say Experts, Patients
04 sept. 2014 07h30 HE
|
Zogenix
SAN DIEGO, Sept. 4, 2014 (GLOBE NEWSWIRE) -- When leading health care professionals, chronic pain patients and pain community advocates gathered recently to kick off National Pain Awareness Month,...
Zogenix to Participate in Morgan Stanley Global Healthcare Conference 2014
02 sept. 2014 16h05 HE
|
Zogenix
SAN DIEGO, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central...
Zohydro(R) ER Demonstrates Sustained 12-Hour Pain Relief
02 sept. 2014 07h30 HE
|
Zogenix
SAN DIEGO, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system...